The Relationship Between Hyperhomocysteinemia and Neurodegeneration

References

• Mandaviya PR , StolkL, HeilSG . Homocysteine and DNA methylation: a review of animal and human literature . Mol. Genet. Metab.113 ( 4 ), 243 – 252 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Vacek TP , KalaniA, VoorMJ, TyagiSC, TyagiN . The role of homocysteine in bone remodeling . Clin. Chem. Lab. Med.51 ( 3 ), 579 – 590 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Petramala L , AccaM, FrancucciCM, D’ErasmoE . Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?J. Endocrinol. Invest.32 ( Suppl. 4 ), 10 – 14 ( 2009 ).
   PubMedGoogle Scholar
• Ansari R , MahtaA, MallackE, LuoJJ . Hyperhomocysteinemia and neurologic disorders: a review . J. Clin. Neurol.10 ( 4 ), 281 – 288 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhuo JM , WangH, PraticòD . Is hyperhomocysteinemia an Alzheimer’s disease (AD) risk factor, an AD marker, or neither?Trends Pharmacol. Sci.32 ( 9 ), 562 – 571 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nachum-Biala Y , TroenAM . B-vitamins for neuroprotection: narrowing the evidence gap . Biofactors38 ( 2 ), 145 – 150 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Malouf M , GrimleyEJ, AreosaSA . Folic acid with or without vitamin B12 for cognition and dementia . Cochrane Database Syst. Rev. ( 4 ), CD004514 ( 2003 ).
   PubMedGoogle Scholar
• Malouf R , Grimley EvansJ . Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people . Cochrane Database Syst. Rev. ( 4 ), CD004514 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Malouf R , Grimley EvansJ . The effect of vitamin B6 on cognition . Cochrane Database Syst. Rev. ( 4 ), CD004393 ( 2003 ).
   PubMedGoogle Scholar
• Malouf R , Areosa SastreA . Vitamin B12 for cognition . Cochrane Database Syst Rev. ( 3 ), CD004326 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Ford AH , AlmeidaOP . Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials . J. Alzheimers Dis.29 ( 1 ), 133 – 149 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Clarke R , BennettD, ParishSet al. B-Vitamin Treatment Trialists’ Collaboration. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals . Am. J. Clin. Nutr.100 ( 2 ), 657 – 666 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Douaud G , RefsumH, de JagerCAet al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment . Proc. Natl Acad. Sci. USA110, 9523 – 9528 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Smith AD , SmithSM, de JagerCAet al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial . PLoS ONE5 ( 9 ), e12244 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• de Jager CA , OulhajA, JacobyR, RefsumH, SmithAD . Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial . Int. J. Geriatr. Psychiatry27 ( 6 ), 592 – 600 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Scalabrino G . The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: lessons learned from its deficiency . Prog. Neurobiol.88 ( 3 ), 203 – 220 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fuso A . The ‘golden age’ of DNA methylation in neurodegenerative diseases . Clin. Chem. Lab. Med.51 ( 3 ), 523 – 534 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Seifter JL , SamuelsMA . Uremic encephalopathy and other brain disorders associated with renal failure . Semin. Neurol.31 ( 2 ), 139 – 143 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Haroon NN , AustinPC, ShahBR, WuJ, GillSS, BoothGL . Risk of dementia in seniors with newly diagnosed diabetes: a population-based study . Diabetes Care38 ( 10 ), 1868 – 1875 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• de Jager J , KooyA, LehertPet al. Long term treatment with metformin in patients with Type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial . BMJ20 ( 340 ), c2181 ( 2010 ).
   Google Scholar
• Kruman II , HendersonGI, BergesonSE . DNA damage and neurotoxicity of chronic alcohol abuse . Exp. Biol. Med. (Maywood)237 ( 7 ), 740 – 747 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• O’Callaghan P , MeleadyR, FitzgeraldT, GrahamI, European COMAC group . Smoking and plasma homocysteine . Eur. Heart. J.23 ( 20 ), 1580 – 1586 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Mayo JN , ChenCH, LiaoFF, BeardenSE . Homocysteine disrupts outgrowth of microvascular endothelium by an iNOS-dependent mechanism . Microcirculation21 ( 6 ), 541 – 550 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lee JT , PengGS, ChenSYet al. Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway . Prog. Neuropsychopharmacol. Biol. Psychiatry45, 21 – 27 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang D , SunX, LiuJ, XieX, CuiW, ZhuY . Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase . Arterioscler. Thromb. Vasc. Biol.35 ( 1 ), 71 – 78 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lin N , QinS, LuoS, CuiS, HuangG, ZhangX . Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro . FEBS J.281 ( 8 ), 2088 – 2096 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yeganeh F , NikbakhtF, BahmanpourS, RastegarK, NamavarR . Neuroprotective effects of NMDA and group I metabotropic glutamate receptor antagonists against neurodegeneration induced by homocysteine in rat hippocampus: in vivo study . J. Mol. Neurosci.50 ( 3 ), 551 – 557 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sudduth TL , PowellDK, SmithCD, GreensteinA, WilcockDM . Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation . J. Cereb. Blood Flow Metab.33 ( 5 ), 708 – 715 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li JG , ChuJ, BarreroC, MeraliS, PraticòD . Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles . Ann. Neurol.75 ( 6 ), 851 – 863 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zou CG , ZhaoYS, GaoSYet al. Homocysteine promotes proliferation and activation of microglia . Neurobiol. Aging31 ( 12 ), 2069 – 2079 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ford AH , FlickerL, AlfonsoHet al. Plasma homocysteine and MTHFRC677T polymorphism as risk factors for incident dementia . J. Neurol. Neurosurg. Psychiatry83 ( 1 ), 70 – 75 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zylberstein DE , LissnerL, BjorkelundCet al. Midlife homocysteine and late-life dementia in women. A prospective population study . Neurobiol. Aging32 ( 3 ), 380 – 386 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hooshmand B , SolomonA, KareholtIet al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study . Neurology75 ( 16 ), 1408 – 1414 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Seshadri S , WolfPA, BeiserASet al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study . Arch. Neurol.65 ( 5 ), 642 – 649 ( 2008 ).
   PubMedGoogle Scholar
• Bonetti F , BromboG, MagonS, ZulianiG . Cognitive status according to homocysteine and B-group vitamins in elderly adults . J. Am. Geriatr. Soc.63 ( 6 ), 1158 – 1163 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• van den Kommer TN , DikMG, ComijsHC, JonkerC, DeegDJ . Homocysteine and inflammation: predictors of cognitive decline in older persons?Neurobiol. Aging31 ( 10 ), 1700 – 1709 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ravaglia G , FortiP, MaioliFet al. Homocysteine and folate as risk factors for dementia and Alzheimer disease . Am. J. Clin. Nutr.82 ( 3 ), 636 – 643 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Schafer JH , GlassTA, BollaKI, MintzM, JedlickaAE, SchwartzBS . Homocysteine and cognitive function in a population-based study of older adults . J. Am. Geriatr. Soc.53 ( 3 ), 381 – 388 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Yang B , FanS, ZhiXet al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis . Nutrients7 ( 1 ), 74 – 90 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch EA , TabibzadehS . Homocysteine in chronic kidney disease . Adv. Clin. Chem.72, 77 – 106 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lakryc EM , MachadoRB, SoaresJMJr, FernandesCE, BaracatEC . What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?Clinics (Sao Paulo)70 ( 2 ), 107 – 113 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Testai FD , GorelickPB . Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders . Arch. Neurol.67 ( 2 ), 148 – 153 ( 2010 ).
   PubMedGoogle Scholar
• Blom HJ , SmuldersY . Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects . J. Inherit. Metab. Dis.34 ( 1 ), 75 – 81 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liew SC , GuptaED . Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases . Eur. J. Med. Genet.58 ( 1 ), 1 – 10 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liu H , YangM, LiGMet al. The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis . J. Neurol. Sci.294 ( 1 ), 74 – 80 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hua Y , ZhaoH, KongY, YeM . Association between the MTHFR gene and Alzheimer’s disease: a meta-analysis . Int. J. Neurosci.121 ( 8 ), 462 – 471 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wu YL , DingXX, SunYH, YangHY, SunL . Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis . J. Neurol. Sci.335 ( 1 ), 14 – 21 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Weisberg IS , JacquesPF, SelhubJet al. The 1298A–>C polymorphism in methylenetetrahydrofolate reductase (MTHFR), in vitro expression and association with homocysteine . Atherosclerosis156 ( 2 ), 409 – 415 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Leclerc D , SibaniS, RozenR . Molecular biology of methylenetetrahydrofolate reductase (MTHFR) and overview of mutations/polymorphisms . In : Madame Curie Bioscience Database . Landes Bioscience ( Ed. ). Austin, TX, USA ( 2000 ). www.ncbi.nlm.nih.gov/books/NBK6561/ .
   Google Scholar
• Weisberg I , TranP, ChristensenB, SibaniS, RozenR . A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity . Mol. Genet. Metab.64 ( 3 ), 169 – 172 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Hickey SE , CurryCJ, TorielloHV . ACMG practice guideline: lack of evidence for MTHFR polymorphism testing . Genet. Med.15 ( 2 ), 153 – 156 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Huang T , TuckerKL, LeeYCet al. Methylenetetrahydrofolate reductase variants associated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in puerto rican adults . J. Nutr.141 ( 4 ), 654 – 659 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Mansoori N , TripathiM, LuthraKet al. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer’s and vascular dementia and their epistatic interaction . Neurobiol. Aging33 ( 5 ), 1003.e1 – 1003.e8 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Anello G , Guéant-RodríguezRM, BoscoPet al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer’s disease . Neuroreport15 ( 5 ), 859 – 861 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Ueland PM . Choline and betaine in health and disease . J. Inherit. Metab. Dis.34 ( 1 ), 3 – 15 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gunduz M , GunduzE, KircelliF, OkurN, OzkayaM . Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism . Int. J. Endocrinol.2012, 109797 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• van Guldener C . Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?Nephrol. Dial. Transplant.21 ( 5 ), 1161 – 1166 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kang A , NigwekarSU, PerkovicVet al. Interventions for lowering plasma homocysteine levels in kidney transplant recipients . Cochrane Database Syst. Rev.5, CD007910 ( 2015 ).
   Google Scholar
• Huang T , RenJ, HuangJ, LiD . Association of homocysteine with Type 2 diabetes: a meta-analysis implementing Mendelian randomization approach . BMC Genomics14, 867 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wijekoon EP , BrosnanME, BrosnanJT . Homocysteine metabolism in diabetes . Biochem. Soc. Trans.35 ( Pt 5 ), 1175 – 1179 ( 2007 ).
   PubMedGoogle Scholar
• Kwak HC , KimYM, OhSJ, KimSK . Sulfur amino acid metabolism in Zucker diabetic fatty rats . Biochem. Pharmacol.96 ( 3 ), 256 – 266 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Das M , GhoseM, BorahNC, ChoudhuryN . A community based study of the relationship between homocysteine and some of the life style factors . Indian J. Clin. Biochem.25 ( 3 ), 295 – 301 ( 2010 ).
   PubMedGoogle Scholar
• Chrysohoou C , PanagiotakosDB, PitsavosCet al. The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the ‘ATTICA’ study . Vasc. Med.9 ( 2 ), 117 – 123 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Desouza C , KeeblerM, McNamaraDB, FonsecaV . Drugs affecting homocysteine metabolism: impact on cardiovascular risk . Drugs62 ( 4 ), 605 – 616 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Zoccolella S , MartinoD, DefazioG, LambertiP, LivreaP . Hyperhomocysteinemia in movement disorders: current evidence and hypotheses . Curr. Vasc. Pharmacol.4 ( 3 ), 237 – 243 ( 2006 ).
   PubMedGoogle Scholar
• Zoccolella S , dell’AquilaC, SpecchioLM, LogroscinoG, LambertiP . Elevated homocysteine levels in Parkinson’s disease: is there anything besides L-dopa treatment?Curr. Med. Chem.17 ( 3 ), 213 – 221 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Miller JW . Homocysteine, folate deficiency, and Parkinson’s disease . Nutr. Rev.60 ( 12 ), 410 – 413 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Duan W , LadenheimB, CutlerRG, KrumanII, CadetJL, MattsonMP . Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson’s disease . J. Neurochem.80 ( 1 ), 101 – 110 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Zoccolella S , LambertiSV, IlicetoG, SantamatoA, LambertiP, LogroscinoG . Hyperhomocysteinemia in L-dopa treated patients with Parkinson’s disease: potential implications in cognitive dysfunction and dementia?Curr. Med. Chem.17 ( 28 ), 3253 – 3261 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sharma M , TiwariM, TiwariRK . Hyperhomocysteinemia: impact on neurodegenerative diseases . Basic Clin. Pharmacol. Toxicol.117 ( 5 ), 287 – 296 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ientile R , Curro’M, FerlazzoN, CondelloS, CaccamoD, PisaniF . Homocysteine, vitamin determinants and neurological diseases . Front. Biosci. (Schol. Ed.)2, 359 – 372 ( 2010 ).
   PubMedGoogle Scholar
• Schneider JA , ArvanitakisZ, BangW, BennettDA . Mixed brain pathologies account for most dementia cases in community-dwelling older persons . Neurology69 ( 24 ), 2197 – 2204 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Genoud V , LauricellaAM, KordichLC, QuintanaI . Impact of homocysteine-thiolactone on plasma fibrin networks . J. Thromb. Thrombolysis38 ( 4 ), 540 – 545 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jakubowski H . The role of paraoxonase 1 in the detoxification of homocysteine thiolactone . Adv. Exp. Med. Biol.660, 113 – 127 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sharma GS , KumarT, DarTA, SinghLR . Protein N-homocysteinylation: from cellular toxicity to neurodegeneration . Biochim. Biophys. Acta1850 ( 11 ), 2239 – 2245 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• McCully KS . Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation . Ann. Clin. Lab. Sci.39 ( 3 ), 219 – 232 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• McCully KS . Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases . Ann. Clin. Lab. Sci.41 ( 4 ), 301 – 314 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Boldyrev A , BryushkovaE, MashkinaA, VladychenskayaE . Why is homocysteine toxic for the nervous and immune systems?Curr. Aging Sci.6 ( 1 ), 29 – 36 ( 2013 ).
   PubMedGoogle Scholar
• Boldyrev AA . Molecular mechanisms of homocysteine toxicity . Biochemistry (Mosc)74 ( 6 ), 589 – 598 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• McCully KS . The active site of oxidative phosphorylation and the origin of hyperhomocysteinemia in aging and dementia . Ann. Clin. Lab. Sci.45 ( 2 ), 222 – 225 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Abushik PA , NiittykoskiM, GiniatullinaRet al. The role of NMDA and mGluR5 receptors in calcium mobilization and neurotoxicity of homocysteine in trigeminal and cortical neurons and glial cells . J. Neurochem.129 ( 2 ), 264 – 274 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• McBean GJ . The transsulfuration pathway: a source of cysteine for glutathione in astrocytes . Amino Acids42 ( 1 ), 199 – 205 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chen NC , YangF, CapecciLMet al. Regulation of homocysteine metabolism and methylation in human and mouse tissues . FASEB J.24 ( 8 ), 2804 – 2817 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Stefaniak J , O’BrienJ . Imaging of neuroinflammation in dementia: a review . J. Neurol. Neurosurg. Psychiatry87 ( 1 ), 21 – 28 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wang Q , LiuY, ZhouJ . Neuroinflammation in Parkinson’s disease and its potential as therapeutic target . Transl. Neurodegener.12, 4 – 19 ( 2015 ).
   Google Scholar
• Surendranathan A , RoweJB, O’BrienJT . Neuroinflammation in Lewy body dementia . Parkinsonism Relat. Disord.21 ( 12 ), 1398 – 1406 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Azizi G , MirshafieyA . The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis . Immunopharmacol. Immunotoxicol.34 ( 6 ), 881 – 895 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Scherer EB , LoureiroSO, VuadenFCet al. Mild hyperhomocysteinemia increases brain acetylcholinesterase and proinflammatory cytokine levels in different tissues . Mol. Neurobiol.50 ( 2 ), 589 – 596 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• da Cunha AA , FerreiraAG, LoureiroSOet al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats . Neurochem. Res.37 ( 8 ), 1660 – 1669 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• McCully KS . Homocysteine and the pathogenesis of atherosclerosis . Expert Rev. Clin. Pharmacol.8 ( 2 ), 211 – 219 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Scherer EB , LoureiroSO, VuadenFCet al. Mild hyperhomocysteinemia increases brain acetylcholinesterase and proinflammatory cytokine levels in different tissues . Mol. Neurobiol.50 ( 2 ), 589 – 596 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• da Cunha AA , FerreiraAG, LoureiroSOet al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats . Neurochem. Res.37 ( 8 ), 1660 – 1669 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pavlov VA , TraceyKJ . The cholinergic anti-inflammatory pathway . Brain Behav. Immun.19 ( 6 ), 493 – 499 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Rosas-Ballina M , TraceyKJ . Cholinergic control of inflammation . J. Intern. Med.265 ( 6 ), 663 – 679 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Guest J , BilginA, HokinB, MoriTA, CroftKD, GrantR . Novel relationships between B12, folate and markers of inflammation, oxidative stress and NAD(H) levels, systemically and in the CNS of a healthy human cohort . Nutr. Neurosci. ( 8 ), 355 – 364 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Eren E , EllidagHY, AydinO, YılmazN . Homocysteine, paraoxonase-1 and vascular endothelial dysfunction: omnibus viis romam pervenitur . J. Clin. Diagn. Res.8 ( 9 ), CE01 – CE04 ( 2014 ).
   PubMedGoogle Scholar
• Wang XC , SunWT, YuCMet al. ER stress mediates homocysteine-induced endothelial dysfunction: modulation of IKCa and SKCa channels . Atherosclerosis242 ( 1 ), 191 – 198 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ravnskov U , McCullyKS . Review and hypothesis: vulnerable plaque formation from obstruction of Vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies . Ann. Clin. Lab. Sci.39 ( 1 ), 3 – 16 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Vermeer SE , van DijkEJ, KoudstaalPJet al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam scan study . Ann. Neurol.51 ( 3 ), 285 – 289 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Tangney CC , AggarwalNT, LiHet al. Vitamin B12, cognition, and brain MRI measures: a cross-sectional examination . Neurology77 ( 13 ), 1276 – 1282 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kamat PK , VacekJC, KalaniA, TyagiN . Homocysteine induced cerebrovascular dysfunction: a link to Alzheimer’s disease etiology . Open. Neurol. J.9, 9 – 14 ( 2015 ).
   PubMedGoogle Scholar
• Fuso A , NicoliaV, CavallaroRA, ScarpaS . DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer’s disease models . J. Nutr. Biochem.22 ( 3 ), 242 – 251 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ji C , KaplowitzN . Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury . World J. Gastroenterol.10 ( 12 ), 1699 – 1708 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Althausen S , PaschenW . Homocysteine-induced changes in mRNA levels of genes coding for cytoplasmic- and endoplasmic reticulum-resident stress proteins in neuronal cell cultures . Brain Res. Mol. Brain Res.84 ( 1 ), 32 – 40 ( 2000 ).
   PubMedGoogle Scholar
• Kim HJ , ChoHK, KwonYH . Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells . J. Nutr. Biochem.19 ( 11 ), 754 – 761 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Slodzinski H , MoranLB, MichaelGJet al. Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies . Clin. Neuropathol.28 ( 5 ), 333 – 343 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Doyle KM , KennedyD, GormanAM, GuptaS, HealySJ, SamaliA . Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders . J. Cell. Mol. Med.15 ( 10 ), 2025 – 2039 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nurk E , TellGS, VollsetSEet al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study . Am. J. Clin. Nutr.79 ( 5 ), 812 – 819 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Stabler SP . Clinical practice. Vitamin B12 deficiency . N. Engl. J. Med.368 ( 2 ), 149 – 160 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zeman M , ZákA, VeckaM, TvrzickáE, PísaríkováA, StankováB . N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination . J. Nutr. Biochem.17 ( 6 ), 379 – 384 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Zinellu A , SotgiaS, PisanuEet al. LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy . Eur. J. Pharm. Sci.47 ( 1 ), 117 – 123 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Drewes YM , PoortvlietRK, BlomJWet al. Homocysteine levels and treatment effect in the PROspective study of pravastatin in the elderly at Risk . J. Am. Geriatr. Soc.62 ( 2 ), 213 – 221 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Santilli F , DavìG, PatronoC . Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective . Vascul. Pharmacol.78, 1 – 9 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Veeranna V , ZalawadiyaSK, NirajAet al. Homocysteine and reclassification of cardiovascular disease risk . J. Am. Coll. Cardiol.58 ( 10 ), 1025 – 1033 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hankey GJ , EikelboomJW, YiQet al. VITATOPS trial study group. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial . Lancet Neurol.11 ( 6 ), 512 – 520 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ferretti G , BacchettiT, SahebkarA . Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials . Prog. Lipid. Res.60, 50 – 73 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Borowczyk K , ShihDM, JakubowskiH . Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1 . J. Alzheimers Dis.30 ( 2 ), 225 – 231 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Perla-Kaján J , JakubowskiH . Paraoxonase 1 protects against protein N-homocysteinylation in humans . FASEB J.24 ( 3 ), 931 – 936 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ataie A , SabetkasaeiM, HaghparastA, MoghaddamAH, KazeminejadB . Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat . Pharmacol. Biochem. Behav.96 ( 4 ), 378 – 385 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Machado FR , FerreiraAG, da CunhaAAet al. Homocysteine alters glutamate uptake and Na+, K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C . Metab. Brain Dis.26 ( 1 ), 61 – 67 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hildebrandt W , SauerR, BonaterraG, DugiKA, EdlerL, KinscherfR . Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status . Am. J. Clin. Nutr.102 ( 5 ), 1014 – 1024 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kamat PK , KalaniA, TyagiSC, TyagiN . Hydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through NMDA receptor in mouse brain endothelial (bEnd3) cells . J. Cell. Physiol.230 ( 2 ), 378 – 394 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kamat PK , KalaniA, GivvimaniS, SathnurPB, TyagiSC, TyagiN . Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice . Neuroscience252, 302 – 319 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fuso A , NicoliaV, RicceriLet al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice . Neurobiol. Aging33 ( 7 ), 1482.e1 – 1482.e16 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Halliday M , MallucciGR . Targeting the unfolded protein response in neurodegeneration: a new approach to therapy . Neuropharmacology76 ( Pt A ), 169 – 174 ( 2014 ).
   PubMedGoogle Scholar